Genesys Capital Overview

  • Investor Type
  • Venture Capital

  • Status
  • Active

  • Professionals
  • 6

Professionals

  • Investments
  • 61

  • Portfolio
  • 9

  • Exits
  • 26

Exits

Genesys Capital General Information

Description

Founded in 2000, Genesys Capital is a venture capital firm based in Toronto, Canada. The firm seeks to invest in early-stage companies based in the United States and Canada and operating in the life sciences, biopharmaceuticals, medical devices, and healthcare service sectors.

Contact Information

Website
www.genesyscapital.com
Year Founded
2000
Investor Status
Actively Seeking New Investments
Trade Association
Canadian Venture Capital and Private Equity (CVCPE)
Primary Investor Type
Venture Capital
Primary Office
  • 123 Front Street West
  • Suite 1503, P.O. Box 34
  • Toronto, Ontario M5J 2M2
  • Canada
+1 (416) 000-0000

Genesys Capital Investments (61)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
CryoStasis 27-Jul-2023 Seed Round 000 Laboratory Services (Healthcare) Pre-Clinical Trials 000000 0000
Veralox Therapeutics 21-Jun-2023 00000 00000 0000 Drug Discovery Clinical Trials - General 00000 00000
Inversago Pharma 14-Oct-2022 00000 00000 000.00 Drug Discovery Clinical Trials - Phase 2 00000 00000
Giiant Pharma 30-Jun-2021 0000 00000 000.00 Drug Discovery Pre-Clinical Trials 00000 00000
Veralox Therapeutics 10-Jun-2021 00000 00000 000.00 Drug Discovery Clinical Trials - General 00000 00000
Flosonics Medical 02-Feb-2021 00000 00000 0000 Monitoring Equipment Generating Revenue 000000 0000
Inversago Pharma 08-Sep-2020 00000 00000 0000 Drug Discovery Clinical Trials - Phase 2 00000 00000
EBT Medical 19-Nov-2019 00000 00000 0000 Therapeutic Devices Generating Revenue 00000 00000
Idbydna 31-Oct-2019 Later Stage VC 000.00 Other Healthcare Technology Systems Generating Revenue
Fusion Pharmaceuticals 25-Mar-2019 Early Stage VC 00000 Drug Discovery Generating Revenue/Not Profitable
You’re viewing 10 of 61 investments. Get the full list »

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Genesys Capital Exits (26)

Company Name Exit Date Exit Type Exit Size
Inversago Pharma 10-Aug-2023 Merger/Acquisition 00.000
Idbydna 04-Jun-2022 000000000000000000
Interface Biologics 01-Jul-2021 000000000 00000000
Profound Medical 21-Jul-2020 000000 0000000000 000.00
Fairhaven Pharmaceuticals 16-Jul-2020 000000000000000000 00.000
Fusion Pharmaceuticals 26-Jun-2020 000 00000
ImpoPharma 25-Jul-2018 0000000000: 000000
Aptinyx 21-Jun-2018 000 00000
Naurex 28-Aug-2015 Merger/Acquisition 00.000
Invitae 12-Feb-2015 IPO 00000
You’re viewing 10 of 26 exits. Get the full list »

Genesys Capital Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Request a free trial

Genesys Capital Team (11)

Name Title Deals Funds Boards Office
Jennifer Williams Director of Finance and Operations & Chief Financial Officer Toronto, Canada
Damian Lamb Co-Founder & Managing Director 00 0 0 Toronto, Canada
Kelly Holman Co-Founder & Managing Director 0 0 0 Toronto, Canada
Jamie Stiff Managing Director 00 0 0 Toronto, Canada
Paras Sharma Senior Associate Toronto, Canada
You’re viewing 5 of 11 team members. Get the full list »

Genesys Capital Co-Investors (49)

Name With Exits Lead Partner Series Industry
AQC Capital 2 0 0 Series chart Industry bar
Anges Québec 0 0 0 Series chart Industry bar
Fonds de solidarite FTQ 0 0 0 Series chart Industry bar
GeneChem 0 0 0 Series chart Industry bar
T1D Fund 0 0 0 Series chart Industry bar
You’re viewing 5 of 49 co-investors. Get the full list »